Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Statement

25 Mar 2025 07:00

RNS Number : 9472B
FD Technologies PLC
25 March 2025
 

FD Technologies plc

Trading update for the 12 months ended 28 February 2025

25th March 2025

Strong FY25 performance with annual contract value ("ACV") at top end of guidance range and cash EBITDA above top end of consensus expectations

 

FY251

FY24

YoY (+/-)

£ million

Expected

Expected

ARR2

81.8

72.5

+13%

ACV3 added

18.0

13.5

+33%

Cash EBITDA4

(14.6)

(18.8)

NM

 

§

KX continued to execute well in the second half of the year, delivering FY bookings growth at the top end of our guidance range and ahead of consensus** expectations, with £18.0 million annual ACV (FY24: £13.5 million), +33 per cent YoY.

§

KX achieved a significant milestone, with annual recurring revenue exceeding $100 million* for the first time, after constant currency growth of 13 per cent to £81.8 million (FY24: £72.5 million), in line with the guidance range.

§

Cash EBITDA was ahead of guidance and above the top end of consensus expectations with a loss of £14.6 million (FY24: loss of £18.8 million).

§

Proven use cases are driving the adoption of KDB.AI, which facilitates real-time AI-powered research assistance, anomaly detection, predictive analytics in capital markets, and satellite imagery analysis and signal processing in aerospace and defence.

§

Market demand for time-series AI is growing as industries shift towards real-time, context-aware AI. KDB.AI's ability to seamlessly combine historical and real-time data with low-latency AI processing sets it apart as a category leader.

§

Following the divestment of MRP (retaining a 49 per cent associate investment in the resulting merged entity, PharosIQ) and First Derivative, we returned £120 million to shareholders and KX closed the year with £56 million net cash and no debt.

§

We enter FY26 with a strong and growing pipeline of expansion and new opportunities across capital markets, aerospace and defence, and industrial IoT. This gives us confidence at this early stage in the year that we can achieve FY26 ARR growth of at least 20%.

Seamus Keating, Group CEO of FD Technologies, commented:

"We made significant strategic and operational progress in FY25. With accelerating ARR growth and better-than-expected operating leverage, KX delivered a strong performance based on good ongoing execution. We restructured our business to focus solely on KX, returned £120 million of value to shareholders, and ensured that KX is well capitalised to execute its strategy for growth and profitability."

Ashok Reddy, CEO of KX, added:

"The strong bookings growth in the period demonstrates that our strategy is working and reflects the benefits of our investments to enhance our go-to-market operations and simplify adoption. We enter FY26 with a strong and growing pipeline of expansion and new opportunities across capital markets, aerospace and defence, and industrial IoT, and view the outlook for the year with confidence."

* £81.8 million ARR restated in US dollars was $103.1 million, using the US$/£ exchange rate of 1.26 on 28 February 2025.

** On 28 February 2025, the company-compiled analyst mean consensus estimates indicated £16.7 million in ACV added during the period (range £16.0-17.0 million), £82.8 million in ARR (range £81.2-84.5 million), and an £18.5 million Cash EBITDA loss (range of £16.3-20.1 million loss). The consensus included estimates from six analysts.

 

1 All figures are only for KX's continuing operations and exclude the divested First Derivative business.

2 Annual recurring revenue: the total value of recurring software revenue expected to be recognised over the next 12 months, on the final day of the reporting period.

3 Annual contract value: the sum of the value of each customer contract signed during the year divided by the number of years in each contract.

4 Earnings before interest, tax, depreciation and amortisation adjusted to exclude share-based payments, capitalised R&D, and exceptional items.

 

Contacts

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Derek Brown, SVP Investor Relations

 

www.fdtechnologies.com

investors@kx.com

Investec Bank plc - Nominated Adviser and Broker

Carlton Nelson

Virginia Bull

+44 (0)20 7597 5970

Goodbody - Euronext Growth Adviser and Broker

Don Harrington

Jason Molins

Tom Nicholson

+353 1 667 0420

 

J.P. Morgan Cazenove - Broker

James A. Kelly

Mose Adigun

+44 (0)20 3493 8000

 

FTI Consulting - Financial PR

Matt Dixon

Dwight Burden

Victoria Caton

+44 (0)20 3727 1000

fdtechnologies@fticonsulting.com

 

About KX

KX is on a mission to make AI a commercial reality for the many by addressing data challenges that impede deployment at scale. By simultaneously ingesting and analysing high volumes of historical and real-time data, KX's AI-ready analytical database enables organizations to unlock the full value of their data to accelerate innovation and make faster, more confident decisions.

 

KX is the world's most performant, cost-effective and energy-efficient analytical database, delivering advanced data algorithms, insights and analytics at unmatched scale and speed. KX is trusted by the world's top investment banks, Aerospace and Defence, high-tech manufacturing and health and life sciences organisations and operates across North America, Europe, and Asia Pacific.

 

For further information, please visit www.fdtechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDXBDDDGUS
Date   Source Headline
9th May 20257:00 amRNSForm 8.3 - FD Technologies plc
8th May 20253:26 pmRNSForm 8.3 - FD Technologies PLC
8th May 20253:22 pmPRNForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20252:49 pmRNSForm 8.3 FD TECHNOLOGIES PLC
8th May 20251:51 pmRNSForm 8.3 - FD TECHNOLOGIES PLC
8th May 202511:24 amRNSForm 8.3 - FD Technologies PLC
8th May 202511:13 amRNSForm 8.5 (EPT/RI) - FD Technologies plc
8th May 202510:02 amRNSForm 8.5 (EPT/NON-RI) FD Technologies plc
8th May 20259:53 amGNWForm 8.5 (EPT/RI) - FD Technologies Plc
8th May 20257:00 amRNSRECOMMENDED ACQUISITION OF FD TECHNOLOGIES PLC
7th May 202511:26 amRNSStatement regarding Possible Offer
16th Apr 20257:44 amRNSHolding(s) in Company
11th Apr 20251:25 pmRNSIssue of Equity
2nd Apr 20258:49 amRNSIssue of Equity
25th Mar 20257:00 amRNSTrading Statement
7th Mar 20259:24 amRNSHolding(s) in Company
4th Feb 20253:57 pmRNSIssue of Equity
4th Feb 20252:45 pmRNSHolding(s) in Company
3rd Feb 20252:36 pmRNSHolding(s) in Company
3rd Feb 202510:19 amRNSHolding(s) in Company
31st Jan 20254:01 pmRNSHolding(s) in Company
30th Jan 20252:09 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTENDER OFFER RESULTS AND TOTAL VOTING RIGHTS
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20252:20 pmRNSRESULTS OF GENERAL MEETING
8th Jan 20251:36 pmRNSHolding(s) in Company
8th Jan 20257:00 amRNSIssue of Equity
19th Dec 20245:00 pmRNSPublication of Circular Notice of GM
19th Dec 20247:00 amRNSProposed Tender Offer
13th Dec 20244:54 pmRNSIssue of Equity
13th Dec 20247:00 amRNSNotification of Long-Term Incentive Award to PDMR
3rd Dec 20247:00 amRNSCOMPLETION OF DIVESTMENT OF FIRST DERIVATIVE
26th Nov 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSProposed Divestment - Satisfaction of Conditions
11th Nov 20244:22 pmRNSNotice of Results
7th Nov 20248:54 amRNSHolding(s) in Company
24th Oct 202412:37 pmRNSResult of General Meeting
8th Oct 20245:00 pmRNSPublication of Circular and Notice of GM
8th Oct 20242:35 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSProposed Divestment
5th Sep 20242:39 pmRNSHolding(s) in Company
1st Aug 20248:43 amRNSTotal Voting Rights
18th Jul 20244:45 pmRNSResult of AGM
9th Jul 20241:56 pmRNSHolding(s) in Company
4th Jul 202410:36 amRNSHolding(s) in Company
2nd Jul 20244:30 pmRNSIssue of Equity
2nd Jul 20242:17 pmRNSHolding(s) in Company
1st Jul 20245:39 pmRNSPDMR Notice and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.